Hayati Yarkadas - Mar 1, 2023 Form 4 Insider Report for Xylem Inc. (XYL)

Role
SVP & President, EU, WI & GLS
Signature
/s/ Callie Plant, by power of attorney for Hayati Yarkadas
Stock symbol
XYL
Transactions as of
Mar 1, 2023
Transactions value $
$690,239
Form type
4
Date filed
3/3/2023, 06:13 PM
Previous filing
Feb 28, 2023
Next filing
May 9, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction XYL Common Stock Tax liability -$10.3K -102 -0.79% $101.09 12.8K Mar 1, 2023 Direct F1
transaction XYL Common Stock Award $0 +4.2K +32.91% $0.00 17K Mar 1, 2023 Direct F2
transaction XYL Common Stock Options Exercise $386K +6.08K +35.79% $63.55 23.1K Mar 2, 2023 Direct
transaction XYL Common Stock Options Exercise $437K +5.04K +21.84% $86.79 28.1K Mar 2, 2023 Direct
transaction XYL Common Stock Sale -$1.6M -15.9K -56.76% $100.43 12.1K Mar 2, 2023 Direct F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction XYL Stock Option (Right to Buy) Award $1.48M +14.6K $101.09 14.6K Mar 1, 2023 Common Stock 14.6K $101.09 Direct F4
transaction XYL Stock Option (Right to Buy) Options Exercise $0 -5.04K -100% $0.00* 0 Mar 2, 2023 Common Stock 5.04K $86.76 Direct F5
transaction XYL Stock Option (Right to Buy) Options Exercise $0 -6.08K -100% $0.00* 0 Mar 2, 2023 Common Stock 6.08K $63.55 Direct F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects units withheld to pay the tax liability incident to the vesting of restricted stock units granted on March 1, 2021 (40) and March 1, 2022 (62) under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016)
F2 Reflects an award of restricted stock units pursuant to the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016) that are scheduled to vest in one third increments on March 1, 2024, March 1, 2025 and March 1, 2026.
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $100.27 to $100.64, inclusive. The reporting person undertakes to provide to Xylem, Inc., any security holder of Xylem, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price with the ranges set forth in Footnote 3 to this Form 4.
F4 Reflects an award of non-qualified stock options pursuant to the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016) that are scheduled to vest in one-third increments on March 1, 2024, March 1, 2025 and March 1, 2026.
F5 The May 7, 2020 option grant vested in one-third increments on February 27, 2021, February 27, 2022 and February 27, 2023.
F6 The March 1, 2022 option grant vested one-third on March 1, 2023, and will vest one-third on each of March 1, 2024 and March 1, 2025.